JILIN AODONG PHARMACEUTICAL GROUP CO., LTD. Funds and ETFs Jilin Aodong Pharmaceutical Group Co., Ltd.
Equities
000623
CNE000000719
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.44 CNY | -0.35% |
|
-1.16% | -4.62% |
| 23/05 | Aodong Medicine Industry's Unit Gets Certificates for 10 Traditional Chinese Medicines | MT |
| 20/05 | Jilin Aodong Pharmaceutical Group Co., Ltd. Approves Dividend for the Year 2023 | CI |
ETFs positioned on Jilin Aodong Pharmaceutical Group Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 112 M€ | +3.74% | - | |
| 0.00% | 7 M€ | +4.71% | - | |
| 0.00% | 32 M€ | +6.51% | - | |
| 0.00% | 34 M€ | +3.93% | - |
Jilin Aodong Pharmaceutical Group Co., Ltd. specializes in the manufacturing and marketing of pharmaceutical products. Besides, the group offers food products. Net sales break down by activity as follows:
- sale of pharmaceutical products (89.4%);
- sale of food products (6.8%);
- other (3.8%).
All sales are in China.
Sector
Pharmaceuticals
Calendar
02/09/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
14.44
CNY
Average target price
22.67
CNY
Spread / Average Target
+56.99%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -4.62% | 2.38B | |
| +41.28% | 734B | |
| +33.43% | 591B | |
| -7.11% | 350B | |
| +15.53% | 315B | |
| +1.35% | 276B | |
| +14.43% | 238B | |
| +8.78% | 206B | |
| -6.09% | 204B | |
| +4.71% | 161B |
- Stock Market
- Equities
- 000623 Stock
- Funds and ETFs Jilin Aodong Pharmaceutical Group Co., Ltd.
